Abstract
The specific mechanisms underlying general anesthesia are primarily unknown. The intravenous general anesthetic etomidate acts by potentiating GABAA receptors, with selectivity for 2 and 3 subunit-containing receptors determined by a single asparagine residue. We generated a genetically modified mouse containing an etomidate-insensitive 2 subunit (2 N265S) to determine the role of 2 and 3 subunits in etomidate-induced anesthesia. Loss of pedal withdrawal reflex and burst suppression in the electroencephalogram were still observed in the mutant mouse, indicating that loss of consciousness can be mediated purely through 3-containing receptors. The sedation produced by subanesthetic doses of etomidate and during recovery from anesthesia was present only in wild-type mice, indicating that the 2 subunit mediates the sedative properties of anesthetics. These findings show that anesthesia and sedation are mediated by distinct GABAA receptor subtypes.
Original language | English |
---|---|
Pages (from-to) | 8608-8617 |
Number of pages | 10 |
Journal | Journal of Neuroscience |
Volume | 23 |
Issue number | 24 |
Publication status | Published - Sept 2003 |
Keywords
- Anaesthetics pharmacology
- Etomidate pharmacology
- Hypnotics and sedatives pharmacology
- Receptors
- GABA-A metabolism